Trinbelimab
Based on 1 Customer Validation
Trinbelimab (r-anti-D) is a recombinant anti-D immunoglobulin that targets the RhD antigen. Trinbelimab exerts immunosuppressive effects to block maternal-fetal RhD alloimmunization. Trinbelimab can be used for the study of maternal-fetal immunity associated with RhD incompatibility.
For research use only. We do not sell to patients.
- Purity: 99%
- CAS No.: 2415078-44-1
- Molecular Weight:145.47 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG1 lambda
Human
RHD
Trinbelimab (r-anti-D) (300 mcg; in vitro) shows specific binding activity to RhD antigen on human red blood cells[1].
Trinbelimab exhibits comparable immunoreactivity to polyclonal anti-D against RhD-positive erythrocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG1 lambda
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 2415078-44-1
-
Appearance Liquid
-
Molecular Weight 145.47 kDa
-
Color Colorless to light yellow
-
SMILES
[Trinbelimab]
-
Synonyms
r-anti-D
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)